Latent tuberculosis and the use of immunomodulatory agents

J Bras Pneumol. 2019 Dec 9;45(6):e20190361. doi: 10.1590/1806-3713/e20190361.
[Article in English, Portuguese]
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antitubercular Agents
  • Humans
  • Latent Tuberculosis*
  • Mycobacterium tuberculosis*

Substances

  • Antitubercular Agents